Virchows Archiv

, Volume 453, Issue 2, pp 177–188

Ultrastructure of myoepithelial cells as a target cell in sialoadenitis of submandibular glands of lupus-prone female NZBxNZWF1 mice

  • Toshiharu Hayashi
  • Hideyuki Hayashi
  • Taeko Fujii
  • Chie Adachi
  • Keiko Hasegawa
Original Article


The changes of myoepithelial cells of sialoadenitis in submandibular glands in lupus-prone female NZB × NZWF1 (B/WF1) mice, a model for human secondary Sjögren’s syndrome (sSS), were examined ultrastructurally. Inflammatory foci consisting of mainly lymphoid cells (lymphocytes and plasma cells) in the interlobular interstitium began to develop from 18 weeks of ages, and those were found within acini from the age of 25 weeks. These were paralleled with the production of anti-double-stranded deoxyribonucleic acid and anti-Ro/SS-A antibodies with age. Infiltrated lymphoid cells consisted of CD4+ T cells and Ig+ (or IgG2a+) cells. Electron microscopy revealed destruction of myoepithelial cells with lysis of basement membranes contacted with either lymphocytes or plasma cells. These led to the destruction (degeneration and necrosis) of the epithelium in striated and intercalated ducts and acinar epithelium. Further destruction of those cells occurred by the invasion of lymphocytes into the epithelial layers. Small numbers of apoptotic myoepithelium and duct epithelium from the age of 25 to 36 weeks and an increase of those cells in survived mice at 44 weeks of age were observed. The present study suggests that the myoepithelium may be one of the target cells and that the destruction of myoepithelial cells by infiltrated lymphoid cells may precede the destruction of acinar ducts and epithelium in sialoadenitis in sSS.


Sjögren’s syndrome Myoepithelial cell Target Sialoadenitis B/WF1 mouse 


  1. 1.
    Amft N, Curnow SJ, Scheel-Toellner D, Devadas A, Oates J, Crocker J, Hamburger J, Ainsworth J, Mathews J, Salmon M, Bowman Sj, Buckley CD (2001) Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structure in Sjögren’s syndrome. Arthritis Rheum 44:2633–2641PubMedCrossRefGoogle Scholar
  2. 2.
    Atkinson JC, Royce LS, Wellner R, Pillemer SR, Bermudez D, Fox PC (1995) Anti-salivary antibodies in primary Sjögren’s syndrome. J Oral Pathol Med 24:206–212PubMedCrossRefGoogle Scholar
  3. 3.
    Carlsöö B, Ostberg Y (1978) Ultrastructural observations on the parotitis autoimmunica in the NZB/NZW hybrid mice. Acta Otalaryngol 85:298–306Google Scholar
  4. 4.
    Chandrasekar B, McGuff S, Aufdermorte TB, Troyer DA, Talal N, Dernande G (1995) Effects of calorie restriction on transforming growth factor β1 and proinflammatory cytokines in murine Sjögren’s syndrome. Clin Immunol Immunopathol 76:291–296PubMedCrossRefGoogle Scholar
  5. 5.
    Croker JA, Kimberly RP (2005) Challenge and candidates in human disease. Trends Immunol 26:580–586PubMedCrossRefGoogle Scholar
  6. 6.
    Defilippi P, Silengo L, Tarone G (1992) α6/β1 integrin (laminin receptor) is down-regulated by tumor necrosis factor α and interleukin-1b in human endothelial cells. J Biol Chem 267:18303–18307PubMedGoogle Scholar
  7. 7.
    Delaleu N, Jonsson R, Köller MM (2005) Sjögren’s syndrome. Eur J Oral Sci 113:101–113PubMedCrossRefGoogle Scholar
  8. 8.
    Gal I, Lakos G, Zeher M (2000) Comparison of the anti-Ro/SSA autoantibody profile between patients with primary and secondary Sjögren’s syndrome. Autoimmunity 32:89–92PubMedCrossRefGoogle Scholar
  9. 9.
    Greenspan JS, Daniels TE, Talal N, Sylvester RA (1974) The histology of Sjögren’s syndrome in labial salivary gland biopsies. Oral Surg 37:217–229PubMedCrossRefGoogle Scholar
  10. 10.
    Haneji N, Nakamura T, Takio K, Yanagi K, Higashiyama H, Saito I, Noji S, Sugino H, Hayashi Y (1997) Identification of alpha-fodrin as a candidate autoantigen in primary Sjogren’s syndrome. Science 276:604–607PubMedCrossRefGoogle Scholar
  11. 11.
    Hasegawa K, Hayashi T (2003) Synthetic CpG olygodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB/NZWF1 mice. Lupus 12:838–845PubMedCrossRefGoogle Scholar
  12. 12.
    Hayashi Y, Hamano H, Haneji N, Ishimaru N, Yanagi K (1995) Biased T cell receptor V beta gene usage during specific stages of the development of autoimmune sialadenitis in the MRL/lpr mouse model of Sjögren’s syndrome. Arthirtis Rheum 38:1077–1084CrossRefGoogle Scholar
  13. 13.
    Hayashi T, Hasegawa K, Ichinohe N (2005) ICAM-1 expression on endothelium and systemic cytokine production in cutaneous neutrophilic lekocytoclastic vasculitis in NZB/NZWF1 mice. Histol Histopathol 20:45–52PubMedGoogle Scholar
  14. 14.
    Hayashi T, Hasegawa K, Sasaki Y, Mori T, Adachi C, Maeda K (2007) Systemic administration of interleukin-4 expressing DNA delays the development of glomerulonephritis and prolongs survivals in lupus-prone female NZB/NZWF1 mice. Nephrol Dial Transplant 22:3131–3138Google Scholar
  15. 15.
    Hayashi T, Shirachi T, Hasegawa K (2001) Relationship between sialoadenitis and periductal laminin expression in the submandibular salivary gland of NZB/NZW F1 Mice. J Comp Pathol 125:110–116PubMedCrossRefGoogle Scholar
  16. 16.
    Hishikawa T, Ogasawara H, Kaneko H, Shirasawa T, Matsuura Y, Sekigawa I, Takasaki Y, Hashimoto H, Hirose S, Handa S, Nagasawa R, Maruyama N (1997) Detection of antibodies to a recombinant gag protein derived from human endogenous retrovirus clone 4-1 in autoimmune disease. Viral Immunol 10:137–147PubMedCrossRefGoogle Scholar
  17. 17.
    Ihrler S, Blasenbreu-Vogt S, Sendelfofert A, Rössle M, Harrison JD, Löhrs U (2004) Regeneration in chronic sialadenitis: an analysis of proliferation and apoptosis based on double immunohistochemical labeling. Virchows Arch 444:356–361PubMedCrossRefGoogle Scholar
  18. 18.
    Ishimaru N, Yoneda T, Saegusa T, Yanagi K, Haneji N, Moriyama K, Saito I, Hayashi Y (2000) Severe destruction of autoimmune lesions with aging in murine Sjögren’s syndrome through Fas-mediated apoptosis. Am J Pathol 156:1557–64PubMedGoogle Scholar
  19. 19.
    Izui S, Elder JH, McConahey PJ, Dixon FJ (1981) Identification of retroviral gp70 and anti-gp70 antibodies involved in circulating immune complexes in NZBNZW mice. J Exp Med 153:1151–1160PubMedCrossRefGoogle Scholar
  20. 20.
    Jacob L, Lety M-A, Monterio RC, Jacob F, Bach J-F, Louvard D (1987) Altered cell-surface proteins, crossreactive with DNA, on spleen cells of autoimmune lupic mice. Proc Natl Acad Sci USA 84:1361–1363PubMedCrossRefGoogle Scholar
  21. 21.
    Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN (2001) Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjögren’s syndrome: high expression of intercellular adhesion molecule-(ICAM-1) in biopsy specimens and cultured cells. Clin Exp Immunol 124:126–133PubMedCrossRefGoogle Scholar
  22. 22.
    Matsumura R, Umemiya K, Kagami M, Tomioka H, Tanabe E, Sugiyama T, Sueishi M, Nakajima A, Azuma M, Okumuea K, Sumida T (1998) Glandular and extraglandular expression of the Fas–Fas ligand and apoptosis in patients with Sjögren’s syndrome. Clin Exp Rheumatol 16:561–568PubMedGoogle Scholar
  23. 23.
    McArhtur CP, Fix NW, Kragel P (1993) Monoclonal antibody detection of laminin in minor salivary glands of patients with Sjögren’s syndrome. J Autoimmun 6:649–661CrossRefGoogle Scholar
  24. 24.
    Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM (2006) Sjögren’s syndrome: why autoimmune epithelitis? Oral Dis 12:523–532PubMedCrossRefGoogle Scholar
  25. 25.
    Miyake S, Sakurai T, Okumura k, Yagita H (1994) Identification of collagen and laminin receptor integrins on murine T lymphocytes. Eur J Immunol 24:2000–2005PubMedCrossRefGoogle Scholar
  26. 26.
    Mok CC, Lau CS (2003) Pathogenesis of systemic lupus erythematosus. J Clin Pathol 56:481–90PubMedCrossRefGoogle Scholar
  27. 27.
    Molina C, Alliende C, Aguilera S, Kwon YJ, Leyton L, Martinez B, Leyton C, Perez P, Gonzalez MJ (2006) Basal lamina disorganization of the acini and ducts of labial salivary gland from patients with Sjögren’s syndrome: association with mononuclear cell infiltration. Ann Rheum Dis 65:178–183PubMedCrossRefGoogle Scholar
  28. 28.
    Nagler RM (2004) Salivary glands and the aging process: mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology 5:223–233PubMedCrossRefGoogle Scholar
  29. 29.
    Nakamura H, Kawakami A, Eguchi K (2006) Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sjögren’s syndrome. Transl Res 148:281–288PubMedCrossRefGoogle Scholar
  30. 30.
    Nakagawa K, Leonard CH (1996) The potential roles of endogenous retoroviruses in autoimmunity. Immunol Rev 152:193–236PubMedCrossRefGoogle Scholar
  31. 31.
    Nakanuma Y, Tsuneyama K, Harada K (2001) Pathology and pathogenesis of intrahepatic bile duct loss. J Hepatobiliary Pancreat Surg 8:303–315PubMedCrossRefGoogle Scholar
  32. 32.
    Nossent JC, Swaak AJ (1998) Systemic lupus erythematosus VII: frequency and impact of secondary Sjögren’s syndrome. Lupus 7:231–234PubMedCrossRefGoogle Scholar
  33. 33.
    Ohlsson M, Skatstein K, Bolstad AI, Johannessen AC, Jonsson R (2001) Fas-induced apoptosis is a rare event in Sjögren’s syndrome. Lab Invest 81:95–105PubMedGoogle Scholar
  34. 34.
    Ohno K, Hattori T, Kagami H, Ueda M (2007) Effects of preceding sialoadenitis on the development of autoimmunity against salivary gland. Oral Dis 13:158–162PubMedCrossRefGoogle Scholar
  35. 35.
    Ping L, Ogawa N, Sugai S (2005) Novel role of CD40 in Fas-dependent apoptosis of cultured salivary epithelial cells from patients with Sjögren’s syndrome. Arthritis Rheum 52:573–581PubMedCrossRefGoogle Scholar
  36. 36.
    Raubenheimer EJ (1987) The myoepithelial cell: embryology, function, and proliferative aspects. Crit Rev Clin Lab Sci 25:161–193PubMedCrossRefGoogle Scholar
  37. 37.
    Reichlin M (1998) Antibodies to Ro and La. Ann Med Intern 149:34–41Google Scholar
  38. 38.
    Salmonson S, Larsson P, Tengner P, Mellquist E, Hjelmstrom P, Wahren-Herlenius M (2002) Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren’s syndrome. Scand J Immunol 55:336–342CrossRefGoogle Scholar
  39. 39.
    Shibata Y, Hishikawa Y, Izumi S, Fujita S, Yamaguchi A, Koji T (2002) Involvement of Fas/Fas ligand in the induction of apoptosis in chronic sialoadenitis of minor salivary glands including Sjögren’s syndrome. Hum Cell 15:52–60PubMedGoogle Scholar
  40. 40.
    Shimizu Y, Van Seventer GA, Horgan KJ, Shaw S (1990) Costimulation of proliferative response of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J Immunol 21:35–42Google Scholar
  41. 41.
    Van Blokland SCA, Versnel MA (2002) Pathogenesis of Sjögren’s syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin Immunol 103:111–124PubMedCrossRefGoogle Scholar
  42. 42.
    Witte T, Matthias T, Arnett FC, Peter HH, Hartung K, Sachse C, Wigand R, Braner A, Kaldon JR, Lakomok HJ, Schmidt RE (2000) IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren’s syndrome. J Rheumatol 27:2617–2620PubMedGoogle Scholar
  43. 43.
    Yasoshima M, Tsuneyama K, Harada K, Sasaki M, Gershwin ME, Nakanuma Y (2000) Immunohistochemical analysis of cell–matrix adhesion molecules and their ligands in the portal tracts of primary biliary cirrosis. J Pathol 190:93–99PubMedCrossRefGoogle Scholar
  44. 44.
    Zelles T, Boros I, Varga G (1999) Membrane stretch and salivary glands—facts and theories. Arch Oral Biol 44:S67–S571PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Toshiharu Hayashi
    • 1
  • Hideyuki Hayashi
    • 1
  • Taeko Fujii
    • 1
  • Chie Adachi
    • 1
  • Keiko Hasegawa
    • 1
  1. 1.Laboratory of Veterinary Pathology, Faculty of AgricultureYamaguchi UniversityYamaguchiJapan

Personalised recommendations